Shandong Weigao Medical Polymer (SHWGF) Stock Price, News & Analysis

Company Overview

Shandong Weigao Medical Polymer Co., Ltd. is a Chinese medical-device manufacturer founded in 1988 and headquartered in Weihai, Shandong Province. The company develops, manufactures and sells medical products, including disposable devices used in infusion, injection and blood transfusion.

Its broader product portfolio includes blood-management and purification products, orthopedic and interventional devices, surgical products, medical equipment and pharmaceutical packaging. Weigao serves healthcare providers in China and sells its products in international markets.

Key Stats

• Today's Range: $0.43 to $0.43
• 50-Day Range: $0.40 to $0.43
• 52-Week Range: $0.40 to $0.73
• Volume: N/A
• Average Volume: 13,560 shs
• Market Capitalization: $1.93 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Shandong Weigao Medical Polymer Stock Analysis - MarketRank™

Shandong Weigao Medical Polymer scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Shandong Weigao Medical Polymer has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Shandong Weigao Medical Polymer has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Shandong Weigao Medical Polymer has a P/B Ratio of 0.55. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.00% of the float of Shandong Weigao Medical Polymer has been sold short.

Short Interest Ratio / Days to Cover

Shandong Weigao Medical Polymer has a short interest ratio ("days to cover") of 0.11, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Shandong Weigao Medical Polymer has recently increased by 347.83%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Shandong Weigao Medical Polymer does not currently pay a dividend.

Dividend Growth

Shandong Weigao Medical Polymer does not have a long track record of dividend growth.

News and Social Media

• Score: 1.2 / 5
• News Sentiment: -0.14

News Sentiment

Shandong Weigao Medical Polymer has a news sentiment score of -0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Shandong Weigao Medical Polymer this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Shandong Weigao Medical Polymer insiders have not sold or bought any company stock.

Percentage Held by Institutions

Shandong Weigao Medical Polymer has minimal institutional ownership at this time.

Company Calendar

• Today: 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SHWGF
• CIK: 1505223
• Web: www.weigaogroup.com
• Phone: 0631-5621999
• Fax: 0631-5621999
• Employees: 13,307
• Year Founded: 1988

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.82 billion
• Price / Sales: 1.06
• Cash Flow: $0.09 per share
• Price / Cash Flow: 4.60
• Book Value: $0.78 per share
• Price / Book: 0.55

Miscellaneous

• Outstanding Shares: 4,491,269,000
• Free Float: N/A
• Market Cap: $1.93 billion
• Optionable: Not Optionable
• Beta: -0.25